spironolactone has been researched along with isotretinoin in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 4 (21.05) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Schmidt, JB | 1 |
| Paller, AS; Sidbury, R | 1 |
| Franz, R | 1 |
| Boisrobert, E; Dreno, B; Gaultier, A; Isvy-Joubert, A; Khammari, A; Le Moigne, M; Nguyen, JM; Saint-Jean, M | 1 |
| Alexis, AF; Harper, JC; Stein Gold, LF; Tan, JKL | 1 |
| Barbieri, JS; James, WD; Margolis, DJ; Spaccarelli, N | 1 |
| Baldwin, HE; Marson, JW | 1 |
| Kahn, B; Ly, B; Ragmanauskaite, L; Yeung, H | 1 |
| Dréno, B; Gollnick, H; Rueda, MJ; Sanders, V; Thiboutot, D | 1 |
| Bhatia, N; Patel, DJ | 1 |
| Barbieri, JS; Shields, A | 1 |
7 review(s) available for spironolactone and isotretinoin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The diagnosis and management of acne.
Topics: Acne Vulgaris; Administration, Topical; Anti-Bacterial Agents; Doxycycline; Estrogens; Female; Humans; Isotretinoin; Male; Mineralocorticoid Receptor Antagonists; Minocycline; Retinoids; Risk Factors; Spironolactone | 2000 |
Approaches to limit systemic antibiotic use in acne: Systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments.
Topics: Acne Vulgaris; Administration, Oral; Administration, Topical; Adult; Anti-Bacterial Agents; Diet, Protein-Restricted; Esthetics; Evidence-Based Medicine; Female; Humans; Isotretinoin; Laser Therapy; Male; Phototherapy; Practice Guidelines as Topic; Risk Assessment; Severity of Illness Index; Spironolactone; Treatment Outcome; Young Adult | 2019 |
An Overview of Acne Therapy, Part 2: Hormonal Therapy and Isotretinoin.
Topics: Acne Vulgaris; Contraceptives, Oral, Hormonal; Dermatologic Agents; Humans; Isotretinoin; Mineralocorticoid Receptor Antagonists; Spironolactone | 2019 |
Acne and the Lesbian, Gay, Bisexual, or Transgender Teenager.
Topics: Abnormalities, Drug-Induced; Acne Vulgaris; Adolescent; Androgen Antagonists; Androgens; Contraception; Culturally Competent Care; Depression; Dermatologic Agents; Estrogens; Female; Gonadotropin-Releasing Hormone; Humans; Isotretinoin; Male; Mental Health; Sex Reassignment Procedures; Sexual and Gender Minorities; Sexual Health; Spironolactone; Suicidal Ideation; Testosterone; Transgender Persons | 2020 |
Oral Antibiotics for Acne.
Topics: Acne Vulgaris; Administration, Oral; Anti-Bacterial Agents; Contraceptives, Oral; Dermatology; Drug Prescriptions; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Isotretinoin; Microbial Sensitivity Tests; Practice Guidelines as Topic; Propionibacterium acnes; Spironolactone; Treatment Outcome | 2021 |
From Breakouts to Bargains: Strategies for Patient-Centered, Cost-effective Acne Care.
Topics: Acne Vulgaris; Adapalene; Benzoyl Peroxide; Cost-Benefit Analysis; Dermatologic Agents; Drug Combinations; Gels; Humans; Isotretinoin; Spironolactone; Treatment Outcome | 2023 |
12 other study(ies) available for spironolactone and isotretinoin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Other antiandrogens.
Topics: Acne Vulgaris; Androgen Antagonists; Cimetidine; Female; Finasteride; Flutamide; Humans; Isotretinoin; Male; Spironolactone | 1998 |
Acne news.
Topics: Acne Vulgaris; Adult; Contraceptives, Oral, Hormonal; Female; Hormones; Humans; Isotretinoin; Spironolactone | 2001 |
Adult female acne treated with spironolactone: a retrospective data review of 70 cases.
Topics: Acne Vulgaris; Adult; Androgen Receptor Antagonists; Back; Contraceptives, Oral; Dermatitis, Seborrheic; Dermatologic Agents; Facial Dermatoses; Female; Humans; Isotretinoin; Middle Aged; Progestins; Retrospective Studies; Risk Factors; Severity of Illness Index; Spironolactone; Treatment Outcome; Young Adult | 2017 |
Treating Acne in Adult Women.
Topics: Acne Vulgaris; Adult; Contraceptives, Oral, Combined; Contraindications, Drug; Dermatologic Agents; Female; Humans; Isotretinoin; Lactation; Medical History Taking; Mineralocorticoid Receptor Antagonists; Pregnancy; Severity of Illness Index; Spironolactone | 2018 |
Changes in the management of acne: 2009-2019.
Topics: Acne Vulgaris; Anti-Bacterial Agents; Antimicrobial Stewardship; Benzoyl Peroxide; Contraceptives, Oral; Dermatology; Drug Administration Schedule; Drug Resistance, Bacterial; Female; Humans; Isotretinoin; Male; Practice Guidelines as Topic; Severity of Illness Index; Sex Hormone-Binding Globulin; Spironolactone; Time Factors | 2020 |